| Date Filed | Type | Description |
| 05/27/2015 |
4
| UBBEN JEFFREY W (Director) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Granted 1,607 shares
@ $0
Paid exercise price by delivering 124 shares
@ $224.63, valued at
$27.9k
|
|
| 02/17/2015 |
SC 13G/A
| Ruane, Cunniff & Goldfarb reports a 10.2% stake in Valeant Pharmaceuticals Intl |
| 02/10/2015 |
SC 13G/A
| BlackRock Inc. reports a 4.8% stake in VALEANT PHARMACEUTICALS INTERNATIONAL |
| 02/02/2015 |
SC 13G/A
| BlackRock Inc. reports a 5.2% stake in VALEANT PHARMACEUTICALS INTERNATIONAL |
| 02/14/2014 |
SC 13G/A
| Ruane, Cunniff & Goldfarb reports a 10.3% stake in Valeant Pharmaceuticals Intl |
| 02/14/2013 |
SC 13G/A
| Ruane, Cunniff & Goldfarb reports a 11.4% stake in Valeant Pharmaceuticals Intl |
| 01/30/2013 |
SC 13G
| BlackRock Inc. reports a 6.7% stake in VALEANT PHARMACEUTICALS INTERNATIO |
| 09/20/2012 |
PRN
| Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes |
| 02/14/2012 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2011 |
SC 13G/A
| VALEANT PHARMACEUTICALS INTERNATIONAL reports a 3.6% stake in VALEANT PHARMACEUTICALS INTERNATIONAL |
| 02/14/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/25/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 10/27/2010 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 10/20/2010 |
4
| DE SILVA RAJIV (COO) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Disposed/sold 261,994 shares
@ $0
Disposed/sold 13,986 options to buy
@ $22.68, valued at
$317.2k
Disposed/sold 81,143 options to buy
@ $22.68, valued at
$1.8M
Disposed/sold 74,627 options to buy
@ $38.47, valued at
$2.9M
|
|
| 10/20/2010 |
4
| Blott Peter J (EVP, CFO) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Disposed/sold 216,889 shares
@ $0
Disposed/sold 23,864 options to buy
@ $16.76, valued at
$400k
Disposed/sold 26,136 options to buy
@ $16.76, valued at
$438k
Disposed/sold 34,000 options to buy
@ $17.72, valued at
$602.5k
Disposed/sold 45,000 options to buy
@ $18.68, valued at
$840.6k
Disposed/sold 20,268 options to buy
@ $14.8, valued at
$300k
Disposed/sold 29,732 options to buy
@ $14.8, valued at
$440k
Disposed/sold 13,500 options to buy
@ $18.55, valued at
$250.4k
Disposed/sold 15,820 options to buy
@ $23.92, valued at
$378.4k
Disposed/sold 4,180 options to buy
@ $23.92, valued at
$100k
Disposed/sold 97,948 options to buy
@ $38.47, valued at
$3.8M
|
|
| 10/20/2010 |
4
| Min Steve T. (EVP, General Counsel) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Disposed/sold 213,069 shares
@ $0
Disposed/sold 23,376 options to buy
@ $17.11, valued at
$400k
Disposed/sold 75,923 options to buy
@ $17.11, valued at
$1.3M
Disposed/sold 83,955 options to buy
@ $38.47, valued at
$3.2M
|
|
| 10/20/2010 |
4
| Pearson J. Michael (CEO and Chairman) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Disposed/sold 1,931,505 shares
@ $0
Disposed/sold 1,024,591 options to buy
@ $12.19, valued at
$12.5M
Disposed/sold 500,000 options to buy
@ $37.41, valued at
$18.7M
|
|
| 10/20/2010 |
4
| Karlson Elisa A. (EVP, Chief Admin Officer) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Disposed/sold 218,663 shares
@ $0
Disposed/sold 25,856 options to buy
@ $15.47, valued at
$400k
Disposed/sold 99,144 options to buy
@ $15.47, valued at
$1.5M
Disposed/sold 55,970 options to buy
@ $38.47, valued at
$2.2M
|
|
| 10/20/2010 |
4
| CHAUDHURI BHASKAR (President) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Disposed/sold 333,438 shares
@ $0
Disposed/sold 20,756 options to buy
@ $16.63, valued at
$345.2k
Disposed/sold 164,212 options to buy
@ $16.63, valued at
$2.7M
Disposed/sold 74,627 options to buy
@ $38.47, valued at
$2.9M
|
|
| 10/08/2010 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 10/01/2010 |
8-K
| Quarterly results |
| 09/30/2010 |
4/A
| Morfit G Mason (Director) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Disposed/sold 24,687 shares
@ $0 |
|
| 09/30/2010 |
4
| ValueAct Holdings, L.P. (10% Owner) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Disposed/sold 24,687 shares
@ $0
Disposed/sold 15,138,358 shares
@ $0 |
|
| 09/30/2010 |
4
| KUGELMAN LARRY (Director) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Disposed/sold 55,589 shares
@ $0
Disposed/sold 10,000 options to buy
@ $8.12, valued at
$81.2k
|
|
| 09/30/2010 |
4
| Provencio Norma Ann (Director) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Disposed/sold 39,574 shares
@ $0 |
|
| 09/30/2010 |
4
| KOPPES RICHARD (Director) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Disposed/sold 54,523 shares
@ $0
Disposed/sold 15,000 options to buy
@ $10.05, valued at
$150.8k
|
|
| 09/30/2010 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Disposed/sold 79,053 shares
@ $0 |
|
| 09/30/2010 |
4
| Morfit G Mason (Director) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Disposed/sold 24,687 shares
@ $0 |
|
| 09/30/2010 |
4
| MELAS KYRIAZI THEO (Director) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Disposed/sold 60,627 shares
@ $0 |
|
| 09/30/2010 |
4
| LONNER ANDERS (Director) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Disposed/sold 12,766 shares
@ $0 |
|
| 09/30/2010 |
4
| STEFANO STEPHEN F. (Director) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL|
Txns:
| Disposed/sold 10,902 shares
@ $0 |
|
| 09/29/2010 |
EFFECT
| Form EFFECT - |
| 09/28/2010 |
25-NSE
| Form 25-NSE - |
| 09/28/2010 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
|